Equity Profile

SYK

Stryker Corporation

Health CareHealth Care Equipment$117.2B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative healthcare equipment and devices. With a market cap of $117 billion, Stryker plays a crucial role in the healthcare sector, focusing on enhancing patient outcomes through advanced surgical and medical solutions.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, missing estimates by 12.63%. The stock remained unchanged the following day, reflecting investor caution.

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to innovation in product development.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Overall, investors are cautious ahead of Stryker's earnings report, especially after the recent EPS miss. The market is looking for signs of recovery in revenue growth and profitability.

Bull Case

If Stryker can show strong revenue growth and improved margins, it could regain investor confidence and drive the stock higher.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise concerns about its growth trajectory and lead to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for this quarter?

Given the recent miss, investors will closely scrutinize EPS to gauge the company's financial health and trajectory.

How is Stryker addressing operational efficiency and cost management?

Improving efficiency is critical for enhancing profitability, especially after the last quarter's disappointing results.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Stryker's potential for a strong recovery in EPS this quarter, given its recent focus on operational efficiency and innovation.

Supporting Evidence

Stryker has a history of beating EPS estimates, with an 88% beat rate in the last 8 quarters.

The options market is pricing in a larger move than the stock has averaged historically, indicating potential for a surprise.

Insider activity shows mixed signals, suggesting uncertainty among insiders about the company's future performance.

Key Risk

If EPS comes in above $3.00, it could significantly shift market sentiment and validate the bullish thesis.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether Stryker can regain momentum after a recent earnings miss.

Bull Confirmed If

An EPS of $3.00 or higher would confirm the bull case, indicating a strong recovery in profitability.

Bear Confirmed If

An EPS below $2.50 would confirm the bear case, raising concerns about the company's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.75%

Pricing rich

The options market is pricing in a modest move around the earnings report, indicating uncertainty among investors.

Options are pricing a larger move than the stock has averaged historically, suggesting heightened expectations.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could rise by about 0.75%, confirming a recovery in investor confidence.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

If the company misses again, history suggests a potential decline of around 0.00%, raising concerns about its growth trajectory.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-NJThomas H. Kean JrRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency initiatives.
2Details on revenue growth in emerging markets.
3Insights into product innovation and pipeline developments.
4Management's outlook on future earnings guidance.
5Responses to analyst questions regarding recent performance and strategy.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, missing estimates by 12.63%. The stock remained unchanged the following day, reflecting investor caution.

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to innovation in product development.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Overall, investors are cautious ahead of Stryker's earnings report, especially after the recent EPS miss. The market is looking for signs of recovery in revenue growth and profitability.

Bull Case

If Stryker can show strong revenue growth and improved margins, it could regain investor confidence and drive the stock higher.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise concerns about its growth trajectory and lead to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for this quarter?

Given the recent miss, investors will closely scrutinize EPS to gauge the company's financial health and trajectory.

How is Stryker addressing operational efficiency and cost management?

Improving efficiency is critical for enhancing profitability, especially after the last quarter's disappointing results.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Stryker's potential for a strong recovery in EPS this quarter, given its recent focus on operational efficiency and innovation.

Supporting Evidence

Stryker has a history of beating EPS estimates, with an 88% beat rate in the last 8 quarters.

The options market is pricing in a larger move than the stock has averaged historically, indicating potential for a surprise.

Insider activity shows mixed signals, suggesting uncertainty among insiders about the company's future performance.

Key Risk

If EPS comes in above $3.00, it could significantly shift market sentiment and validate the bullish thesis.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether Stryker can regain momentum after a recent earnings miss.

Bull Confirmed If

An EPS of $3.00 or higher would confirm the bull case, indicating a strong recovery in profitability.

Bear Confirmed If

An EPS below $2.50 would confirm the bear case, raising concerns about the company's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.75%

Pricing rich

The options market is pricing in a modest move around the earnings report, indicating uncertainty among investors.

Options are pricing a larger move than the stock has averaged historically, suggesting heightened expectations.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could rise by about 0.75%, confirming a recovery in investor confidence.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

If the company misses again, history suggests a potential decline of around 0.00%, raising concerns about its growth trajectory.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-NJThomas H. Kean JrRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency initiatives.
2Details on revenue growth in emerging markets.
3Insights into product innovation and pipeline developments.
4Management's outlook on future earnings guidance.
5Responses to analyst questions regarding recent performance and strategy.